Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, December 2005, p. 5133-5135, Vol. 49, No. 12
0066-4804/05/$08.00+0 doi:10.1128/AAC.49.12.5133-5135.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.
Istituto di Malattie Infettive e Medicina Pubblica,1 Istituto di Anatomia Patologica,2 Centro Gestione Presidenza Medicina e Chirurgia, Università Politecnica delle Marche,3 Laboratorio di Microbiologia Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I-Lancisi-Salesi, Ancona, Italy,4 Istituto di Farmacologia Preclinica e Clinica, Università degli Studi di Firenze, Florence, Italy,5 Department of Pathology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas,6 Audie L. Murphy Division, South Texas Veterans Health Care System, San Antonio, Texas7
Received 23 July 2005/ Returned for modification 1 September 2005/ Accepted 3 October 2005
We investigated the in vitro and in vivo activities of caspofungin against Aspergillus terreus. The drug increased survival and reduced tissue fungal burden in neutropenic mice. Therefore, our data support the role of caspofungin in treating systemic infections due to this emerging pathogen.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»